지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 저널정보
- 대한비만학회 Journal of Obesity & Metabolic Syndrome Journal of Obesity & Metabolic Syndrome Vol.25 No.1
- 발행연도
- 2016.1
- 수록면
- 19 - 23 (5page)
이용수
초록· 키워드
오류제보하기
Background: It has not been determined which obesity index might be most appropriate to predict nonalcoholic fatty liver disease in Asian populations. This study aimed to evaluate the usefulness of the waist-to-height ratio in assessing patients with nonalcoholic fatty liver disease and to identify the optimal cut-off values useful for predicting nonalcoholic fatty liver disease. Methods: Receiver operating characteristic curve analyses were conducted in order to assess the accuracy of the waist circumference, body mass index, and waist-to-height ratio for detecting nonalcoholic fatty liver disease among 616 women aged 20 years or older. To evaluate the optimal value of anthropometric indices, the Youden J-index (sensitivity+specificity-1) was used. Results: The area under the ROC curve of waist-to-height ratio was highest among anthropometric obesity indices as follows: 0.776 (0.731-0.822) for waist circumference, 0.775 (0.728-0.822) for body mass index, and 0.792 (0.748-0.836) for waist-to-height ratio, respectively. Using a waist-to-height ration cut-off value of 0.49, the sensitivity and specificity for detecting nonalcoholic fatty liver disease were 72.3 % and 74.7%, respectively. Conclusion: These results demonstrated that the waist-to-height ratio may be a better obesity index for identifying individuals at risk for nonalcoholic fatty liver disease in Korean women.
목차
등록된 정보가 없습니다.
참고문헌 (18)
참고문헌 신청
Angulo P / 2007 / GI epidemiology : nonalcoholic fatty liver disease / Aliment Pharmacol Ther 25:883~889
Matteoni CA / 1999 / Nonalcoholic fatty liver disease : a spectrum of clinical and pathological severity / Gastroenterology 116:1413~1419
Marchesini G / 2001 / Nonalcoholic fatty liver disease : a feature of the metabolic syndrome / Diabetes 50:1844~1850
Targher G / 2010 / Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease / N Engl J Med 363:1341~1350
van der Poorten D / 2008 / Visceral fat : a key mediator of steatohepatitis in metabolic liver disease / Hepatology 48:449~457
Matteoni CA / 1999 / Nonalcoholic fatty liver disease : a spectrum of clinical and pathological severity / Gastroenterology 116:1413~1419
Marchesini G / 2001 / Nonalcoholic fatty liver disease : a feature of the metabolic syndrome / Diabetes 50:1844~1850
Targher G / 2010 / Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease / N Engl J Med 363:1341~1350
van der Poorten D / 2008 / Visceral fat : a key mediator of steatohepatitis in metabolic liver disease / Hepatology 48:449~457
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different?
Clinical and Molecular Hepatology
2023 .04
-
The Impact of Body Composition on the Prognosis of Nonalcoholic Fatty Liver Disease
Gut and Liver
2024 .07
-
Sarcopenia as a Novel Risk Factor for Nonalcoholic Fatty Liver Disease
Journal of Obesity & Metabolic Syndrome
2020 .01
-
The effect of moderate alcohol consumption on nonalcoholic fatty liver disease
Clinical and Molecular Hepatology
2023 .04
-
Implications of comorbidities in nonalcoholic fatty liver disease
Clinical and Molecular Hepatology
2023 .04
-
Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations
Clinical and Molecular Hepatology
2022 .10
-
Personalized medicine in nonalcoholic fatty liver disease
Clinical and Molecular Hepatology
2022 .10
-
A crystal ball to forecast treatment responsiveness in nonalcoholic fatty liver disease
Clinical and Molecular Hepatology
2022 .07
-
The growing burden of non-alcoholic fatty liver disease on mortality
Clinical and Molecular Hepatology
2023 .04
-
Changing the nomenclature from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease is more than a change in terminology
Clinical and Molecular Hepatology
2023 .04
-
Hepatocellular carcinoma surveillance in non-alcoholic fatty liver disease – who and how?
Clinical and Molecular Hepatology
2023 .04
-
Probiotics for treatment of nonalcoholic fatty liver disease: It is worth a try
Clinical and Molecular Hepatology
2021 .01
-
Nonalcoholic Fatty Liver Disease Is a Stepping Stone in the Path toward Diabetes Mellitus
Gut and Liver
2019 .01
-
Non-obese or lean nonalcoholic fatty liver disease matters, but is it preventable or inevitable in light of its risk factors?
Clinical and Molecular Hepatology
2023 .04
-
KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Clinical and Molecular Hepatology
2021 .01
-
Nonalcoholic fatty liver disease-based risk prediction of adverse pregnancy outcomes: Ready for prime time?
Clinical and Molecular Hepatology
2022 .01
-
Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
Clinical and Molecular Hepatology
2023 .02
-
Association of nonalcoholic fatty liver disease with incident dementia later in life among elderly adults
Clinical and Molecular Hepatology
2022 .07
-
비알코올성지방간의 유관 인자 임상 연구: 종양표지자, 심박변이도, 사상체질
JSCM : Journal of Sasang constitutional medicine
2019 .01
-
Effect of Korean Red Ginseng in chronic liver disease
Journal of Ginseng Research
2017 .10
이 논문의 저자 정보
최근 본 자료
댓글(0)
0